» Articles » PMID: 32759795

Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Aug 8
PMID 32759795
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

RAB proteins (RABs) represent the largest subfamily of Ras-like small GTPases that regulate a wide variety of endosomal membrane transport pathways. Their aberrant expression has been demonstrated in various malignancies and implicated in pathogenesis. Using The Cancer Genome Atlas (TCGA) database, we analyzed the differential expression and clinicopathological association of genes in pancreatic ductal adenocarcinoma (PDAC). Of the 62 genes analyzed, five and ) exhibited statistically significant upregulation, while five ( and ) were downregulated in PDAC as compared to the normal pancreas. Racially disparate expression was also reported for and . However, no clear trend of altered expression was observed with increasing stage and grade, age, and gender of the patients. PDAC from occasional drinkers had significantly higher expression of compared to daily or weekly drinkers, whereas expression was significantly higher in social drinkers, compared to occasional ones. The expression of was significantly reduced in PDAC from diabetic patients, whereas was significantly lower in pancreatitis patients. More importantly, a significant association of high expression of and , and low expression of and was observed with poorer survival of PC patients. Together, our study suggests potential diagnostic and prognostic significance of RABs in PDAC, warranting further investigations to define their functional and mechanistic significance.

Citing Articles

A Comparison of Tools That Identify Tumor Cells by Inferring Copy Number Variations from Single-Cell Experiments in Pancreatic Ductal Adenocarcinoma.

Oketch D, Giulietti M, Piva F Biomedicines. 2024; 12(8).

PMID: 39200223 PMC: 11351975. DOI: 10.3390/biomedicines12081759.


The Role of Rab GTPases in the development of genetic and malignant diseases.

Erol O, Senocak S, Aerts-Kaya F Mol Cell Biochem. 2023; 479(2):255-281.

PMID: 37060515 DOI: 10.1007/s11010-023-04727-x.


Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma.

Weng D, He L, Chen X, Lin H, Ji D, Lu S Front Immunol. 2023; 13:1055412.

PMID: 36713370 PMC: 9877459. DOI: 10.3389/fimmu.2022.1055412.


RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma.

Peng H, Zhu E, Wang J, Du X, Wang C, Yang M Front Pharmacol. 2022; 13:989655.

PMID: 36120364 PMC: 9478551. DOI: 10.3389/fphar.2022.989655.


RAB21 controls autophagy and cellular energy homeostasis by regulating retromer-mediated recycling of SLC2A1/GLUT1.

Pei Y, Lv S, Shi Y, Jia J, Ma M, Han H Autophagy. 2022; 19(4):1070-1086.

PMID: 35993307 PMC: 10012929. DOI: 10.1080/15548627.2022.2114271.


References
1.
Opdam F, Echard A, Croes H, van den Hurk J, van de Vorstenbosch R, Ginsel L . The small GTPase Rab6B, a novel Rab6 subfamily member, is cell-type specifically expressed and localised to the Golgi apparatus. J Cell Sci. 2000; 113 ( Pt 15):2725-35. DOI: 10.1242/jcs.113.15.2725. View

2.
Wolfgang C, Herman J, Laheru D, Klein A, Erdek M, Fishman E . Recent progress in pancreatic cancer. CA Cancer J Clin. 2013; 63(5):318-48. PMC: 3769458. DOI: 10.3322/caac.21190. View

3.
Hooper S, Gaggioli C, Sahai E . A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion. Br J Cancer. 2009; 102(2):392-402. PMC: 2816649. DOI: 10.1038/sj.bjc.6605469. View

4.
Dateyama I, Sugihara Y, Chiba S, Ota R, Nakagawa R, Kobayashi T . RABL2 positively controls localization of GPCRs in mammalian primary cilia. J Cell Sci. 2018; 132(2). DOI: 10.1242/jcs.224428. View

5.
Fang Z, Li C, Li S . MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A. Exp Ther Med. 2019; 17(5):3921-3928. PMC: 6468329. DOI: 10.3892/etm.2019.7435. View